Preparation method for fused protein of human C-type diuresis promotion sodium peptide and human serum albumins and its product

The invention discloses a preparing method of fusion protein of human C-type natriuretic peptide (CNP) and human serum albumin (HSA) and product, belonging to the technical field of long-acting recombinant fusion protein drug, which comprises the following steps: adopting overlapping PCR technique;...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LEI JIANYONG, DOU WENFANG, CHEN WEI, ZHANG LIANFEN, JIN JIAN, SHI ZHONGPING, LI JIE, XU ZHENGHONG
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LEI JIANYONG
DOU WENFANG
CHEN WEI
ZHANG LIANFEN
JIN JIAN
SHI ZHONGPING
LI JIE
XU ZHENGHONG
description The invention discloses a preparing method of fusion protein of human C-type natriuretic peptide (CNP) and human serum albumin (HSA) and product, belonging to the technical field of long-acting recombinant fusion protein drug, which comprises the following steps: adopting overlapping PCR technique; splitting HSA cDNA and CNP cDNA; integrating HSA-CNP cDNA fusion gene obtained without any connecting peptide being added into chromosome of a host; and expressing in the host system. The fusion protein of the invention includes a first area with at least 85% sequence homologous with human serum albumin and the second area with at least 85% sequence homologous with human C-type natriuretic peptide, individual amino acid residue substitution, deletion and addition can be carried out with the characteristics of the fusion protein being not changed.The fusion protein of the invention has extended half-life in the human body, with the physiological property of the human C-type natriuretic peptide being kept, improved s
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN101063123BB</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN101063123BB</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN101063123BB3</originalsourceid><addsrcrecordid>eNqNizEKwkAQRdNYiHqHwT6QGPAACYqVWNiHNTtLBrI7y85sYeXVjSEHsPrw_nvb4vNIGE0yShzAo45swXEClwUtxMSKFIAdjNmbAF2p74hgKScUkp_geWmFZ-ghYlSyCCbYNRFMMzfTK3sKshykS2nzoPti48wkeFh3Vxyvl2d3KzFyjxLNgAG17-51VVfnpj41bdv8JX0Bt_lJtw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Preparation method for fused protein of human C-type diuresis promotion sodium peptide and human serum albumins and its product</title><source>esp@cenet</source><creator>LEI JIANYONG ; DOU WENFANG ; CHEN WEI ; ZHANG LIANFEN ; JIN JIAN ; SHI ZHONGPING ; LI JIE ; XU ZHENGHONG</creator><creatorcontrib>LEI JIANYONG ; DOU WENFANG ; CHEN WEI ; ZHANG LIANFEN ; JIN JIAN ; SHI ZHONGPING ; LI JIE ; XU ZHENGHONG</creatorcontrib><description>The invention discloses a preparing method of fusion protein of human C-type natriuretic peptide (CNP) and human serum albumin (HSA) and product, belonging to the technical field of long-acting recombinant fusion protein drug, which comprises the following steps: adopting overlapping PCR technique; splitting HSA cDNA and CNP cDNA; integrating HSA-CNP cDNA fusion gene obtained without any connecting peptide being added into chromosome of a host; and expressing in the host system. The fusion protein of the invention includes a first area with at least 85% sequence homologous with human serum albumin and the second area with at least 85% sequence homologous with human C-type natriuretic peptide, individual amino acid residue substitution, deletion and addition can be carried out with the characteristics of the fusion protein being not changed.The fusion protein of the invention has extended half-life in the human body, with the physiological property of the human C-type natriuretic peptide being kept, improved s</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110615&amp;DB=EPODOC&amp;CC=CN&amp;NR=101063123B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110615&amp;DB=EPODOC&amp;CC=CN&amp;NR=101063123B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LEI JIANYONG</creatorcontrib><creatorcontrib>DOU WENFANG</creatorcontrib><creatorcontrib>CHEN WEI</creatorcontrib><creatorcontrib>ZHANG LIANFEN</creatorcontrib><creatorcontrib>JIN JIAN</creatorcontrib><creatorcontrib>SHI ZHONGPING</creatorcontrib><creatorcontrib>LI JIE</creatorcontrib><creatorcontrib>XU ZHENGHONG</creatorcontrib><title>Preparation method for fused protein of human C-type diuresis promotion sodium peptide and human serum albumins and its product</title><description>The invention discloses a preparing method of fusion protein of human C-type natriuretic peptide (CNP) and human serum albumin (HSA) and product, belonging to the technical field of long-acting recombinant fusion protein drug, which comprises the following steps: adopting overlapping PCR technique; splitting HSA cDNA and CNP cDNA; integrating HSA-CNP cDNA fusion gene obtained without any connecting peptide being added into chromosome of a host; and expressing in the host system. The fusion protein of the invention includes a first area with at least 85% sequence homologous with human serum albumin and the second area with at least 85% sequence homologous with human C-type natriuretic peptide, individual amino acid residue substitution, deletion and addition can be carried out with the characteristics of the fusion protein being not changed.The fusion protein of the invention has extended half-life in the human body, with the physiological property of the human C-type natriuretic peptide being kept, improved s</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNizEKwkAQRdNYiHqHwT6QGPAACYqVWNiHNTtLBrI7y85sYeXVjSEHsPrw_nvb4vNIGE0yShzAo45swXEClwUtxMSKFIAdjNmbAF2p74hgKScUkp_geWmFZ-ghYlSyCCbYNRFMMzfTK3sKshykS2nzoPti48wkeFh3Vxyvl2d3KzFyjxLNgAG17-51VVfnpj41bdv8JX0Bt_lJtw</recordid><startdate>20110615</startdate><enddate>20110615</enddate><creator>LEI JIANYONG</creator><creator>DOU WENFANG</creator><creator>CHEN WEI</creator><creator>ZHANG LIANFEN</creator><creator>JIN JIAN</creator><creator>SHI ZHONGPING</creator><creator>LI JIE</creator><creator>XU ZHENGHONG</creator><scope>EVB</scope></search><sort><creationdate>20110615</creationdate><title>Preparation method for fused protein of human C-type diuresis promotion sodium peptide and human serum albumins and its product</title><author>LEI JIANYONG ; DOU WENFANG ; CHEN WEI ; ZHANG LIANFEN ; JIN JIAN ; SHI ZHONGPING ; LI JIE ; XU ZHENGHONG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN101063123BB3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2011</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>LEI JIANYONG</creatorcontrib><creatorcontrib>DOU WENFANG</creatorcontrib><creatorcontrib>CHEN WEI</creatorcontrib><creatorcontrib>ZHANG LIANFEN</creatorcontrib><creatorcontrib>JIN JIAN</creatorcontrib><creatorcontrib>SHI ZHONGPING</creatorcontrib><creatorcontrib>LI JIE</creatorcontrib><creatorcontrib>XU ZHENGHONG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LEI JIANYONG</au><au>DOU WENFANG</au><au>CHEN WEI</au><au>ZHANG LIANFEN</au><au>JIN JIAN</au><au>SHI ZHONGPING</au><au>LI JIE</au><au>XU ZHENGHONG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Preparation method for fused protein of human C-type diuresis promotion sodium peptide and human serum albumins and its product</title><date>2011-06-15</date><risdate>2011</risdate><abstract>The invention discloses a preparing method of fusion protein of human C-type natriuretic peptide (CNP) and human serum albumin (HSA) and product, belonging to the technical field of long-acting recombinant fusion protein drug, which comprises the following steps: adopting overlapping PCR technique; splitting HSA cDNA and CNP cDNA; integrating HSA-CNP cDNA fusion gene obtained without any connecting peptide being added into chromosome of a host; and expressing in the host system. The fusion protein of the invention includes a first area with at least 85% sequence homologous with human serum albumin and the second area with at least 85% sequence homologous with human C-type natriuretic peptide, individual amino acid residue substitution, deletion and addition can be carried out with the characteristics of the fusion protein being not changed.The fusion protein of the invention has extended half-life in the human body, with the physiological property of the human C-type natriuretic peptide being kept, improved s</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN101063123BB
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
title Preparation method for fused protein of human C-type diuresis promotion sodium peptide and human serum albumins and its product
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T19%3A17%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LEI%20JIANYONG&rft.date=2011-06-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN101063123BB%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true